| Dr Phyllis Arnella Braxton, LCPC | |
|
8957 Edmonston Rd, Suite M, Greenbelt, MD 20770-1005 | |
| (240) 667-4290 | |
| (703) 563-9698 |
| Full Name | Dr Phyllis Arnella Braxton |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 8957 Edmonston Rd, Greenbelt, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073797650 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | LC-1071 (Maryland) | Secondary |
| 101YP2500X | Counselor - Professional | 0701002241 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Phyllis Arnella Braxton, LCPC 41 Morton Rd, Falmouth, VA 22405-1488 Ph: (240) 423-0061 | Dr Phyllis Arnella Braxton, LCPC 8957 Edmonston Rd, Suite M, Greenbelt, MD 20770-1005 Ph: (240) 667-4290 |
News Archive
According to the 2010 census, the nation's median age has increased to 37.2, up from 35.3 in 2000. The aging trend held up in every state ... Older states, such as Maine, Vermont, West Virginia and New Hampshire, may have less time than others to prepare for challenges such as providing long-term care for a growing elderly population.
Researchers at the Istituto Superiore di Sanità (Italian National Institute of Health) have shown that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had already been circulating in Italy many weeks before the first autochthonous (native) case was documented on February 21st this year.
A $250,000 grant from the Centers for Disease Control and Prevention (CDC) will support a Rhode Island Hospital research study aimed at reducing the state's leading cause of accidental death among adults. Researchers will explore the use and effectiveness of statewide prescription monitoring programs (PMP) in reducing the number of accidental overdose deaths involving prescription opioids like OxyContin and Vicodin in both Rhode Island and Connecticut.
Opexa Therapeutics, Inc., a leading cell therapy company developing Tovaxin for multiple sclerosis, today announced the successful completion of two separate meetings with the U.S. Food and Drug Administration regarding the Company's planned development program for Tovaxin.
› Verified 2 days ago
Dionna Casey Steeple, LCPC, NCC Counselor Medicare: Medicare Enrolled Practice Location: 7474 Greenway Center Dr, Greenbelt, MD 20770 Phone: 240-304-3327 | |
Zulma Y Salmeron, LGPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 7474 Greenway Center Dr Ste 700b, Greenbelt, MD 20770 Phone: 240-304-4155 Fax: 240-513-4155 | |
Laura Scott, Counselor Medicare: Not Enrolled in Medicare Practice Location: 7474 Greenway Center Dr Ste 202, Greenbelt, MD 20770 Phone: 240-304-3327 | |
Ana Patricia Rivera, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 7225 Hanover Pkwy Ste C, Greenbelt, MD 20770 Phone: 240-459-3074 | |
Steven Hall, CSC-AD Counselor Medicare: Not Enrolled in Medicare Practice Location: 7708 Hanover Pkwy Apt 101, Greenbelt, MD 20770 Phone: 202-374-4226 | |
Tristin Malone, LGPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 7474 Greenway Center Dr Ste 730, Greenbelt, MD 20770 Phone: 301-345-1022 Fax: 301-560-5558 | |
Dr. David Chauncey Hall, Counselor Medicare: Not Enrolled in Medicare Practice Location: 7474 Greenway Center Dr Ste 730, Greenbelt, MD 20770 Phone: 301-345-1022 |